<DOC>
	<DOCNO>NCT02614300</DOCNO>
	<brief_summary>Pulmonary rehabilitation program part multidisciplinary treatment chronic respiratory disease COPD ( chronic obstructive pulmonary disease ) . Although clinical guideline diseases non-cystic fibrosis bronchiectasis ( nCFBE ) discuss benefit program quality life exercise tolerance , evidence intervention nCFBE patient insufficient . Longer study need large sample size optimize maximize response maintain long-term benefit . The present study aim examine effect exercise tolerance pulmonary rehabilitation program combine respiratory physiotherapy patient nCFBE . It randomize controlled clinical trial total duration 24 month . The intervention perform 12 week period 12 month maintenance . This multicenter study involve follow Hospitals : Hospital Clinic , Hospital la Plató Hospital del Mar Barcelona , Hospital Josep Trueta Girona , Royal Infirmary Edinburgh Fondazione Maugeri di Lumezzane Italy . Subjects randomize three group ratio ( 1 : 1 : 1 ) ( 1 ) Pulmonary Rehabilitation ( 2 ) Chest Physiotherapy ( 3 ) Pulmonary Rehabilitation + Chest Physiotherapy . Hospital la Plató Barcelona responsible carry Control Group . The primary endpoint test `` endurance shuttle walk test '' .</brief_summary>
	<brief_title>The Role Pulmonary Rehabilitation Airways Clearance Techniques Multidisciplinary Management Non CF Bronchiectasis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Bronchiectasis</mesh_term>
	<criteria>Aged 5080 year ; No perform regular physiotherapy treatment physical training ( ≤ 1 time/week ) ; Stable disease [ change chronic therapy ( inhaled systematic ) usual respiratory symptom ( accord medical evaluation ) spirometry last 4 week prior study recruitment ] ; Regular cough expectoration ; Ability follow exercise program ; Ability perform clinical test , understand process purpose study ; A history least 2 exacerbation previous year require antibiotic treatment ; Signed informed consent . Active smoker , exsmokers less 1 year prior recruitment and/or history &gt; 20 smoking packs/year ; FEV1 &lt; 30 % or/and TLC &lt; 40 % ; Diagnosis cystic fibrosis , sarcoidosis , pulmonary fibrosis , active tuberculosis non tuberculosis mycobacterial infection , Diagnosis asthma COPD primary respiratory disease associate secondary bronchiectasis , Patients unstable cardiac disease locomotor difficulty preclude exercise ( eg , severe arthritis severe peripheral vascular disease ) ; Chronic respiratory failure and/or oxygen therapy ; Frequent haemoptysis ( ≥ 2 times/month ) ; Participation PR program year prior inclusion study protocol ; Participation CP program 1 month prior inclusion ; Any physical psychological disorder interferes protocol compliance ; Participation clinical trial imply change usual pharmacological treatment last 6 month recruitment ; Being wait list lung transplantation transplant .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>pulmonary rehabilitation</keyword>
	<keyword>chest physiotherapy</keyword>
	<keyword>non-cystic fibrosis bronchiectasis</keyword>
	<keyword>exercise tolerance</keyword>
	<keyword>bronchiectasis</keyword>
	<keyword>respiratory therapy</keyword>
</DOC>